| Q30869985 | A network biology workflow to study transcriptomics data of the diabetic liver |
| Q37337449 | A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. |
| Q40722349 | APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases |
| Q39279036 | Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults |
| Q84988426 | Association between polymorphisms in the signal transducer and activator of transcription and dilated cardiomyopathy in the Chinese Han population |
| Q34971028 | Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver disease |
| Q38073597 | Fetal metabolic programming and epigenetic modifications: a systems biology approach |
| Q36411266 | Genetic analysis of nonalcoholic fatty liver disease within a Caribbean-Hispanic population |
| Q34646183 | Genetic determinants of hepatic steatosis in man. |
| Q30235398 | Genetic predisposition in nonalcoholic fatty liver disease |
| Q36710902 | Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis |
| Q34505214 | Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population |
| Q33618518 | Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease |
| Q26778035 | Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico |
| Q52605264 | Identification of key genes in non‑alcoholic fatty liver disease progression based on bioinformatics analysis. |
| Q54976725 | Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage. |
| Q47187755 | Polychlorinated biphenyls disrupt hepatic epidermal growth factor receptor signaling |
| Q36108365 | Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice |
| Q64376813 | Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling |
| Q36140409 | Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease. |
| Q90540850 | Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution |
| Q55233965 | The Interleukin-20 Cytokine Family in Liver Disease. |